• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Thorne Relaunches Gut Health Test with Microbiome Wipe

    Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports

    GC Rieber Foundations Expand Philanthropic Efforts

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    GC Rieber Foundations Expand Philanthropic Efforts

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Botanical Ingredient MorActive Evidenced to Relieve Back Discomfort

    Cargill’s Stevia Sustainability Program Benchmarked by FSA

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Thorne Relaunches Gut Health Test with Microbiome Wipe

    Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports

    GC Rieber Foundations Expand Philanthropic Efforts

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Thorne Relaunches Gut Health Test with Microbiome Wipe

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Beyond Raw Launches Concept X Pre-Workout Line

    Botanical Ingredient MorActive Evidenced to Relieve Back Discomfort

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Applied Food Sciences, Inc.

    Ecuadorian Rainforest

    Aiya America, Inc. (Aiya Matcha)

    ESHA Research

    Atlantia Clinical Trials
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Applied Food Sciences, Inc.

    Ecuadorian Rainforest

    Aiya America, Inc. (Aiya Matcha)

    ESHA Research

    Atlantia Clinical Trials
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    The Wild West Sells More than Just CBD

    Self-determined GRAS is not a cure-all for NDINs, so be responsible and conduct the necessary safety and toxicology work.

    The Wild West Sells More than Just CBD
    Related CONTENT
    • Sunflower Hemp Co
    • FDA Sends Latest Round of Warning Letters on CBD & Cites Safety Concerns
    • DSHEA Milestone Marks Inflection Point for Industry
    • Federal Agencies Warn Company Marketing Unapproved CBD Products
    • CBD in the Clinic: How Practitioners View Life After the Farm Bill
    By Todd Harrison, Venable11.05.19
    Walking around Supply Side West this year I was not only struck by how many companies are hawking various forms of hemp/CBD ingredients, but also the wide variety of dietary ingredients I have never seen before, or that are being presented in new ways. 

    Nanotechnology continues to gain traction, but as I walked around I asked myself, “Are these ingredients NDIs? Are the ingredients reasonably expected to be safe? Are they Generally Recognized As Safe (GRAS) for use in conventional foods which are sold as functional foods?”

    I decided to inquire about these various new ingredients, especially the nano-particle-size ingredients, including quite a few nano-sized CBD products. The answers I received left me dumbstruck.

    One common answer for some of the ingredients was that “We are grandfathered so safety studies are not required.” So, I asked, “Do you know how a nano-sized-particle would act in the body?” And the only answer has been that it would be “more absorbable and effective.” Occasionally, I would receive the answer “we have self-determined GRAS.” These responses left me wondering if anyone understands the Dietary Supplement Health and Education Act (DSHEA), what constitutes an “old” dietary ingredient, and what GRAS means.

    In the end, it became clear to me that this is still, unfortunately, a Wild West industry chasing after fool’s gold with no idea whether the highly-standardized ingredients and nano-particle ingredients are actually safe for use in food or dietary supplements, other than “we have never had a safety issue that we are aware of.”

    NDI & Safety Reviews
    I thought this might be a good time to review what is a new dietary ingredient and what is not, and what really is required for GRAS. I want to simplify this discussion on what is and what is not an NDI. If an ingredient was not marketed prior to Oct. 14, 1994 it is an NDI subject to notification unless available in the
    food supply.

    This definition is quite simple. We do not need to review FDA’s draft guidance to determine whether a nano-particle dietary ingredient was marketed prior to Oct. 14, 1994, because we all know the answer is that it was not.

    Moreover, basic chemistry and physiology teaches us that nano-sized particles will act differently in the body than normal-sized molecules. There may be a cascade effect that could be either good or bad. For instance, it is my understanding from people I trust on toxicology issues that nano-sized CBD is likely not as safe as CBD in general. Thus, even if we can establish that CBD is safe, it might not be safe as a nano-sized particle.

    This is basic chemistry. Yet, the industry is not asking the safety question; all we hear is that it’s more absorbable, therefore it must be more effective. And that is simply not true. Similarly, an isolated constituent may have a different safety profile compared to when it is part of the whole plant. Thus, many herbalists believe in the entourage effect of the whole herb as opposed to the isolated chemical.

    Indeed, we know that bioactivity can be upregulated or downregulated by a particular constituent based on the presence of other molecules. But hey, the constituent is part of a grandfathered dietary ingredient or food, and therefore a notification is not required, right?

    In essence, the common default position is to make the legal argument instead of doing the right thing by conducting the necessary safety assessment on the ingredient. I am fairly certain most highly standardized extracts are safe. And I can make a reasonable legal argument that if the constituent is present in the product at levels that have been generally available in pre-1994 supplements, then an NDIN is not necessary. But is that in fact the right answer? I would argue no, it’s not. 

    For sure, we overcome the issue related to whether the structure of the law permits the marketing of the ingredient, but it ignores the substantive part of the laws about whether the ingredient poses a significant or unreasonable risk of harm if it is an “old” dietary ingredient, or the ingredient has a reasonable expectation of safety if it is an NDI that is not subject to notification.  

    Instead, it appears the default position is the original dietary ingredient is safe, therefore highly standardized extracts or isolated constituents must also be safe, which may be true but it has never been actually studied. This line of logic continues, well if the molecule is safe then the nano particle must be safe, which again may or may not be true. Without the appropriate toxicology work being done we will never know the answer.

    Of course, FDA is a relatively small agency and does not have the ability to enforce all aspects of every law. Thus, the agency relies on its enforcement discretion until it becomes aware of an issue. However, that does not mean an ingredient is safe. Rather, it simply means FDA doesn’t have the resources to act. 

    Magic GRAS
    Then there is the magic of self-affirmed GRAS; self-affirmed GRAS seems to cure all. If I have a self-affirmed GRAS position or paper, I can market to my heart’s content. Unfortunately, the vast majority of self-affirmed GRAS positions I have seen over the years are as good as the paper they were written on.

    To make things worse, companies are told by consultants within the industry not to file GRAS notifications and that they can rely on private data. But how can you have general recognition if the data is not publicly available and is limited to a few choice people? You can’t. Yet, companies are told by consultants and lawyers you can, and that is how DMAA became, prior to its downfall, a popular sports nutrition ingredient.

    Indeed, DMAA is the classic case of form over substance. A company is told by a lawyer that it’s a constituent of a plant and therefore may be marketed without an NDIN. When that legal argument failed, the company fell back on “the ingredient is GRAS, therefore we may market it.”

    To this day, I am not quite sure why anyone thought the limited safety data established GRAS, but the 11th Circuit Court of Appeals agreed with FDA’s assessment mainly because the agency said it was not GRAS. Indeed, in shorthand, how can an ingredient be GRAS if the experts at FDA disagree with that assessment? Indeed, by definition if experts disagree, one cannot have general recognition. With that said, FDA could be wrong, and if you have a strong bench of well-respected toxicologists you may be able to overcome the issue in court. Then again, you may not. 

    Recently, a company marketing a beverage learned that its supplier’s self-determined GRAS did not pass FDA muster, leaving that company with not many choices other than to remove the ingredient. The fact is that both the company and the supplier are at fault, as neither one critically assessed the self-GRAS determination. I am sure they had lawyers and consultants who told them to the contrary.

    From my perspective, if the self-determined GRAS dossier does not meet FDA’s requirements, my advice is go back, do a proper gap analysis, and do the necessary studies. But it seems we are too often more interested in shortcuts than doing the work the correct way.

    Here is the best way to handle self-determined GRAS: is the data sufficient to satisfy FDA? If it is, file the notification, unless there is a legitimate reason not to. If it is not filed, take it to an independent toxicologist (one who did not participate in the drafting of the GRAS dossier, or in the expert panel) to assess the document and provide a gap analysis. If it passes that review, then rely on it. 

    In the end, I can sum up my positions this way: do the right thing, and do your job. Let’s stop chasing fool’s gold and stop worrying about whether there is a legal argument available whereby companies can avoid notification, or whether the ingredient is precluded. Go straight to “does it meet the applicable safety standard?” Stop looking for a way around it.


    Todd Harrison
    Venable

    Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.
    Related Searches
    • GRAS
    • Herb
    • Beverage
    • Nanotechnology
    Related Knowledge Center
    • Herbs & Botanicals
    • Quality & Safety
    • Regulations
    Suggested For You
    Sunflower Hemp Co Sunflower Hemp Co
    FDA Sends Latest Round of Warning Letters on CBD & Cites Safety Concerns FDA Sends Latest Round of Warning Letters on CBD & Cites Safety Concerns
    DSHEA Milestone Marks Inflection Point for Industry DSHEA Milestone Marks Inflection Point for Industry
    Federal Agencies Warn Company Marketing Unapproved CBD Products Federal Agencies Warn Company Marketing Unapproved CBD Products
    CBD in the Clinic: How Practitioners View Life After the Farm Bill CBD in the Clinic: How Practitioners View Life After the Farm Bill
    CBD Regulatory Status Update: The Chaos Continues CBD Regulatory Status Update: The Chaos Continues
    Clearing Up Chaos in the Modern Nutraceuticals Market Clearing Up Chaos in the Modern Nutraceuticals Market
    The CBD Craze: Still Only the Beginning The CBD Craze: Still Only the Beginning
    Cannovia: Clearing Up CBD Market Confusion Cannovia: Clearing Up CBD Market Confusion
    Area Code 420 Has Arrived Area Code 420 Has Arrived
    Charlotte’s Web Introduces Hemp Extract-Infused Gummies Charlotte’s Web Introduces Hemp Extract-Infused Gummies
    Levagen PEA: A Legal Answer to CBD’s Issues Levagen PEA: A Legal Answer to CBD’s Issues
    DSHEA Discussion: Assessing Standards for Scientific Evidence DSHEA Discussion: Assessing Standards for Scientific Evidence
    Move Over Mainstream, Healthy Foods Are Here to Stay Move Over Mainstream, Healthy Foods Are Here to Stay

    Related Content

    • Sunflower Hemp Co

      ...
      Colby Terip, Owner 09.15.21

    • Breaking News | Herbs & Botanicals | Industry & Market News | Quality & Safety | Regulations | Regulatory News
      FDA Sends Latest Round of Warning Letters on CBD & Cites Safety Concerns

      FDA Sends Latest Round of Warning Letters on CBD & Cites Safety Concerns

      Agency notes data gaps about CBD toxicity and concerns about potential harm.
      11.26.19

    • Breaking News | Dietary Supplements | Industry & Market News | Quality & Safety | Regulations

      DSHEA Milestone Marks Inflection Point for Industry

      Where does the path forward lead?
      10.29.19


    • Breaking News | Herbs & Botanicals | Industry & Market News | Regulations | Regulatory News
      Federal Agencies Warn Company Marketing Unapproved CBD Products

      Federal Agencies Warn Company Marketing Unapproved CBD Products

      ‘These actions should send a message to the broader market about complying with FDA requirements,’ says Acting FDA Commissioner.
      10.22.19

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Medical Nutrition | Quality & Safety | Regulations
      CBD in the Clinic: How Practitioners View Life After the Farm Bill

      CBD in the Clinic: How Practitioners View Life After the Farm Bill

      Holistic, functional medicine practitioners see therapeutic value of CBD and have confidence in its efficacy for a range of common health concerns.
      By Erik Goldman, Holistic Primary Care 10.07.19

      Trending
      • Leaven Essential To Launch Branded Botanical Extracts To Global Markets | Nutraceuticals World
      • Oregon Files Lawsuit Against GNC | Nutraceuticals World
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk In Older Adults | Nutraceuticals World
      • Coca-Cola To Phase Out Honest Tea Brand By Year’s End, Citing Supply Chain Challenges | Nutraceuticals World
      Breaking News
      • Thorne Relaunches Gut Health Test with Microbiome Wipe
      • Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      • GC Rieber Foundations Expand Philanthropic Efforts
      • Danone Celebrates 10th anniversary of Grant Program for Probiotics Research
      • Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      GC Rieber Foundations Expand Philanthropic Efforts
      Coatings World

      Latest Breaking News From Coatings World

      PPG Hosts The Future of Coatings' Technology Innovation Day in Amsterdam
      Azelis Expands Presence in India with Acquisition of Chemo India and Unipharm Laboratories
      Teknos Publishes Sustainability Report
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Pediatric Medical Device Competition Reveals Five Finalists
      Medical Device Packaging Market to Reach $34B by 2027
      Penumbra Secures CE Mark for its Advanced Mechanical Thrombectomy Tech
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Mirum Pharmaceuticals Acquires San Diego-based Satiogen
      Catalyst Biosciences Sells Complement Portfolio to Vertex Pharmaceuticals
      Insmed Appoints Drayton Wise as Chief Commercial Officer
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      La Roche-Posay Launches Matte Moisturizer for Oily Skin
      3 Amorepacific Employees Stole $2.3 Million
      L'Oreal CEO Nicolas Hieronimus On Sustainability Initiatives
      Happi

      Latest Breaking News From Happi

      Thayers Natural Remedies Celebrates 175 Years with Social Campaign
      Former Model Shirley Powell’s Indie Beauty Brand LaJeanell Comprises Gender Inclusive Skincare and Makeup
      L’Oréal's New UVMune 400 Sun Filtering Technology Protects Skin From Ultra-Long UVA Rays
      Ink World

      Latest Breaking News From Ink World

      Flint Group Flexible Packaging Europe Implements Further Price Increase
      Nazdar Launches 205 Series Inks for Roland TrueVIS SG2 and VG2 Series Printers
      Quad Adds Landa S10P Nanographic Printing Press
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      AWA to host 22nd Global Release Liner Industry Conference & Exhibition
      Domino assists Grace Label with supply chain disruptions
      Rotocon wins AI Business Excellence Award
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Rael Raises $35M in Series B Funding
      Schobertechnologies Offers Rotary Web-fed Converting Solutions
      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Study Confirms Knee Shapes are Highly Individualized
      Stryker Launches EasyFuse Dynamic Compression for Foot & Ankle
      Extremity Medical Rolls Out OMNI Stable Ankle Fracture System
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      InnovationLab Acquires Flexible Printed Battery Technology from Evonik
      Canatu Receives IATF 16949:2016 Certification
      Applied Materials Announces 2Q 2022 Results

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login